Follow-up of the Natural Course of the Small EUS-suspected Gastric Gastointestinal Stromal Tumors

Gastric gastrointestinal stromal tumors (GISTs) less than 2 cm are usually followed up conservatively. However, little is known about the natural course of small GISTs. The goal of this study was to evaluate the clinical course of the small EUS-suspected gastric GISTs and to determine the size predicting subsequent progression with increased malignant potential.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tumor Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Gastrointestinal Stromal Tumors Neoplasms Neoplasms by Histologic Type Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(1) a small tumor size, less than 3 cm;
(2) patients declined surgical intervention at initial identification of the lesion;
(3) at least two EUS follow-up procedures were recorded;
(4) the EUS follow-up period was more than 24 months.

Exclusion criteria

(1) a tumor size, larger than 3 cm;
(2) less two EUS follow-up procedures were recorded;
(3) the EUS follow-up period was less 24 months.

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start: 1997
Primary completion: 2008
Study completion: 2008
First posted: Mar 10, 2010
Registry last updated: Mar 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed